Development: Phase IIb-IV
Although we operate independently, CEDRA is a division of Worldwide Clinical Trials (WCT). As such, CEDRA is able to support global trials both as a portal to WCT and as a research site.
WCT is a leading therapeutically-focused CRO applying deep therapeutic expertise to help customers achieve their drug development goals. WCT focuses on late-stage drug development services for pharmaceutical and biotechnology companies.
Primary Research Areas
- Cardiovascular
- Central nervous system
- Chronic Inflammatory Disease
- Metabolic/endocrinology
- Oncology
Development-Phase Capabilities
- Protocol and program development
- Feasibility
- Project management
- Medical monitoring
- Clinical monitoring and site management
- Data management
- Biostatistics and data analysis
- Medical writing
- Pharmacovigilance
- Regulatory consulting
- Investigator meetings
- Drug and supply depot
- Quality assurance